Ftse Mib
32.917,87
0,77%
DAX
18.068,21
0,26%
S&P 500
5.473,23
0,77%
NASDAQ
17.857,02
0,95%
Bitcoin
66.401,81
-0,36%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Revolution Medicines Inc (RVMD) Revolution Medicines Inc (RVMD) Notizie

Revolution Medicines Inc

RVMD
37,10
-1,52 (-3,94%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:03:51
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/6/202422:05GLOBERevolution Medicines to Participate in Goldman Sachs 45th..
08/5/202422:02GLOBERevolution Medicines Reports First Quarter 2024 Financial..
01/5/202422:05GLOBERevolution Medicines to Report Financial Results for First..
09/4/202421:34GLOBERevolution Medicines Announces Publication on the Discovery..
08/4/202417:36GLOBERevolution Medicines Announces Publications on the Discovery..
04/4/202422:05GLOBERevolution Medicines to Participate in Upcoming Investor..
28/3/202421:05GLOBERevolution Medicines to Deliver Multiple Presentations at..
05/3/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:23EDGAR2Form S-3ASR - Automatic shelf registration statement of..
26/2/202423:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202422:05GLOBERevolution Medicines Reports Fourth Quarter and Full Year..
26/2/202422:04EDGAR2Form 8-K - Current report
20/2/202422:05GLOBERevolution Medicines to Report Financial Results for Fourth..
09/2/202423:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202422:05GLOBERevolution Medicines to Participate in Upcoming Investor..
24/1/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:18EDGAR2Form 144 - Report of proposed sale of securities
09/1/202420:15EDGAR2Form 8-K - Current report
04/1/202413:00GLOBERevolution Medicines to Present at 42nd Annual J.P...
20/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202300:22EDGAR2Form 144 - Report of proposed sale of securities
14/12/202323:48EDGAR2Form 144 - Report of proposed sale of securities
21/11/202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:14EDGAR2Form 144 - Report of proposed sale of securities
16/11/202320:58EDGAR2Form CERT - Certification by an exchange approving..
15/11/202322:04EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
15/11/202302:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202302:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202302:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/11/202315:20EDGAR2Form 8-K - Current report
09/11/202315:10GLOBERevolution Medicines Completes Acquisition of EQRx
08/11/202317:30GLOBERevolution Medicines and EQRx Stockholders Approve EQRx..
06/11/202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:05GLOBERevolution Medicines Reports Third Quarter 2023 Financial..
06/11/202322:05EDGAR2Form 8-K - Current report
01/11/202312:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/11/202312:11EDGAR2Form 425 - Prospectuses and communications, business..
01/11/202312:08EDGAR2Form 8-K - Current report
01/11/202312:00GLOBELeading Independent Proxy Advisory Firms ISS and Glass Lewis..
31/10/202321:15GLOBERevolution Medicines to Report Financial Results for Third..
24/10/202300:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202312:13EDGAR2Form 425 - Prospectuses and communications, business..
23/10/202312:11EDGAR2Form 8-K - Current report
22/10/202308:30GLOBERevolution Medicines Presents Promising Clinical Activity..
13/10/202317:54EDGAR2Form 8-K - Current report
13/10/202317:50GLOBERevolution Medicines Presents Encouraging Clinical Data for..
04/10/202322:05GLOBERevolution Medicines to Present New Clinical Data at Major..
Apertura: 38,15 Min: 36,48 Max: 38,47
Chiusura: 38,62

La tua Cronologia

NASDAQ
RVMD
Revolution Medicines
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network